B cells expressing potent and broadly neutralizing antibodies to HIV-1 have been found in many infected individuals, suggesting that adaptive immunity has the capacity to defeat viral escape. Gao et al. uncover an intermediate stage in this process when viral escape from one ''helper'' B cell lineage selects variants that drive a separate B cell lineage toward broad neutralization.
Understanding the natural course of any infection and the emergence of adaptive immunity promises clues to the design of prophylactic vaccines. While the progressive course of HIV-1 infection is relentless, analyses of HIV-1 specific adaptive immunity have been highly informative (Corti and Lanzavecchia, 2013) . In this issue of Cell, Gao et al. (2014) move a step further toward understanding the dynamic interplay between viral evolution and adaptive immune response. The HIV-1 envelope spike (Env) facilitates virus entry into host cells and is the focus of much of this immune activity (West et al., 2014) . However, initial waves of adaptive immunity and the early production of neutralizing antibodies is rapidly defeated through viral escape. Founder viruses that express mutant versions of the original immune targets overtake infection and escape neutralization (Burton et al., 2012) . Nevertheless, after many years of persistent infection, some individuals contain memory B cells that express Env-specific antibodies able to neutralize variants of the original ''autologous'' virus. Importantly, these antibodies also display potent and broad cross-reactivity to ''heterologous'' virus never seen by the host (West et al., 2014) . How these broadly neutralizing antibodies (bnAbs) develop in infected individuals remains a central issue for the field.
The existence of Env-specific bnAbs suggests that the adaptive immune response can potentially defeat viral escape. Elegant longitudinal studies of a single infected individual recently mapped the structural changes that accompany dynamic coevolution of bnAbs and viral escape mutants (Liao et al., 2013) . These studies revealed the presence of a mature CH103 B cell lineage that expressed bnAbs recognizing the D loop of the CD4 binding site (CD4bs) in HIV-1 Env. The ongoing evolutionary tension between virus escape and neutralizing antibody production was clearly evident early in this donor (CH505) and extended for years after initial infection. BnAb activity could be seen in highly mutated and clonally related members of this CH103 B cell lineage. Predicted intermediate precursors in this lineage could be constructed with capacity to neutralize autologous variants without bnAb function. Now Gao et al. (Gao et al., 2014) (Figure 1) . Hence, cooperation between separate B cell lineages underlies gradual acquisition of bnAb reactivity.
While individuals expressing bnAbs do not eradicate infection, these potent antibodies can be effective under conditions of passive transfer. Recent studies in humanized mouse models and macaques demonstrate the efficacy of combinations of bnAbs to block initial disease and suppressing ongoing infection (Barouch et al., 2013) . Unfortunately, the predicted germ-line ancestors of these highly-mutated bnAbs rarely bind the founder Env. This conundrum leads to new vaccine strategies that modify initial immunogens to recruit unmutated ancestors coupled to boost regimes using HIV-1 variant antigens (Jardine et al., 2013) . Based on the current studies (Gao et al., 2014) , it is possible that the initial desirable ''helper'' lineages are quite distinct from those that will eventually drive broad neutralization. It is equally plausible that variant immunogens may serve to bypass these early steps in the development of bnAbs.
All proposed mechanisms of bnAb development depend on the ongoing capacity of Env-specific memory B cells to respond to viral escape. At early stages of infection, viral escape is followed by altered patterns of antibody recognition and neutralization of initial escapees (Liao et al., 2013) . Eventual maturation of an effective memory B cell lineage toward broad neutralization must also be actively driven by variant antigen (Gao et al., 2014) . This dynamic evolution in memory B cell specificity occurs within secondary lymphoid tissues in specialized microenvironments called germinal centers (GC) (McHeyzer-Williams et al., 2012; Victora and Nussenzweig, 2012) . How these variant antigens drive some GC B cells to evolve Env-specific bnAb remains a central practical issue for vaccine design.
Promoting effective B cell memory (Tarlinton and Good-Jacobson, 2013) and the development of bnAb specificities remains a central challenge to field. The studies by Gao et al. propose a new sequential mechanism that drives the gradual development of these vital bnAb specificities and promises to inform immunogen design for the next generation of HIV-1 vaccines. (235, 240, 241) are detected with distinct reactivity patterns across a wide spectrum of variant Env proteins. Importantly, CH235 drives complete viral escape across multiple Env epitopes. However, in doing so this CH235 response selects Env variants containing mutations in the D loop of the CD4bs. These D loop mutants display enhanced binding to the CH103 lineage members to provide the antigenic drive toward maturation and broadly neutralizing antibody (bnAb) reactivity. In this manner, the two memory B cell lineages cooperate in the development of HIV-1 Env-specific bnAbs.
